Kevin T Conroy Insider Trading
Get free email notifications about insider trading for Kevin T Conroy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kevin T Conroy. Kevin T Conroy is a President & CEO in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and a President and CEO in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and a VP, General Counsel in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and a President & CEO in EXACT SCIENCES CORP ($EXAS) and a President and CEO in EXACT SCIENCES CORP ($EXAS) and a Director in Adaptive Biotechnologies Corp ($ADPT) and a Director in Epizyme, Inc. ($EPZM) and a Director in ARYA SCIENCES ACQUISITION CORP. ($ARYA).
Address: 502 S. ROSA ROAD MADISON 53719 WI
Companies in which Kevin T Conroy is an Insider
Adaptive Biotechnologies Corp
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Kevin T Conroy: Director
Holdings: 1,504 shares
Latest Transaction: Feb 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARYA SCIENCES ACQUISITION CORP.
Industry: BLANK CHECKS [6770]
Position of Kevin T Conroy: Director
Holdings: 0 shares
Latest Transaction: Jul 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Epizyme, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kevin T Conroy: Director
Holdings: 11,282 shares
Current Value: $135,948
Latest Transaction: Apr 01 2021
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EXACT SCIENCES CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Kevin T Conroy: President and CEO, President & CEO
Holdings: 776,736 shares
Current Value: $14,346,314
Latest Transaction: May 05 2021
$EXAS Market Capitalization: $2.00B
$EXAS Previous Close: $18.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
THIRD WAVE TECHNOLOGIES INC /WI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Kevin T Conroy: President and CEO, President & CEO, VP, General Counsel
Holdings: 47,513 shares
Latest Transaction: Jul 28 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Kevin T Conroy
Sentiment: All, ADPT, ARYA, EPZM, EXAS, TWTI
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 131.09 | 19,240 | 2,522,172 | 757,496 | 776.7 K to 757.5 K (-2.48 %) |
| May 05 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Grant | A | 64.74 | 328 | 21,235 | 776,736 | 776.4 K to 776.7 K (+0.04 %) |
| May 05 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 131.09 | 19,240 | 2,522,172 | 757,496 | 776.7 K to 757.5 K (-2.48 %) |
| May 05 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Grant | A | 64.74 | 328 | 21,235 | 776,736 | 776.4 K to 776.7 K (+0.04 %) |
| Apr 01 2021 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 8.71 | 1,723 | 15,007 | 11,282 | 9.6 K to 11.3 K (+18.02 %) |
| Mar 03 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 20,575 | 0 | 20,575 | |
| Mar 03 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 138.42 | 9,796 | 1,355,962 | 799,163 | 809 K to 799.2 K (-1.21 %) |